of cases occur in women

Between 15% and


of women have melasma

Melasma is common between the ages of 20 and


Melasma is a very common dermatosis characterized by dark spots, mainly on the face, and can have serious adverse effects on the social life of patients. This dermatological condition is common in women between 20 and 50 years, but it can also affect men.

Many methods and alternative treatments are currently available, and LASER treatment has proven to be a very successful and common alternative both as an isolated treatment or in combination with other therapies.

Low fluence Q-SWITCHED LASER treatment for melasma was approved by the FDA in 2011. Q-SWITCHED LASERs operate by issuing nanosecond (ns) pulses specifically to the melanocytes (photothermal and photoacoustic effects), preventing the skin and adjacent tissues from being affected by the heat generated.

Women make up 90% of clinical melasma cases. Occurrence is noted primarily in higher pigmented phenotypes (Fitzpatrick III to V).

It is estimated that between 15% and 35% of adult Brazilian women are carriers of the disease. Genetic predisposition is one clinical factor, as more than 40% of patients mention relatives who are also affected¹.

See the results